PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Department and Rheumatology Research Group, Vall d\'Hebron Hospital Research Institute, 08035, Barcelona, Spain. toni.julia@vhir.org.\', \'Rheumatology Department and Rheumatology Research Group, Vall d\'Hebron Hospital Research Institute, 08035, Barcelona, Spain.\', \'HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.\', \'Rheumatology Department and Rheumatology Research Group, Vall d\'Hebron Hospital Research Institute, 08035, Barcelona, Spain. sara.marsal@vhir.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-90797-0
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34075090
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34075090>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34075090>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all